20167-22-0 Usage
Description
(2-amino-1,3-thiazol-4-yl)methyl carbamimidothioate is a carbamate derivative with the molecular formula C5H7N3S2. It is a chemical compound that has been studied for its potential antineoplastic activity and use in cancer therapy.
Uses
Used in Pharmaceutical Research and Drug Development:
(2-amino-1,3-thiazol-4-yl)methyl carbamimidothioate is used as a subject of study for its potential antineoplastic activity and use in cancer therapy. It is being investigated for its potential as an inhibitor of specific enzymes involved in cancer cell growth and proliferation.
Used in Cancer Therapy:
(2-amino-1,3-thiazol-4-yl)methyl carbamimidothioate is used as a potential therapeutic agent against cancer. It is being studied for its potential to inhibit specific enzymes involved in cancer cell growth and proliferation, making it a promising candidate for cancer treatment.
Used in Therapeutic Agent Development:
(2-amino-1,3-thiazol-4-yl)methyl carbamimidothioate is used as a potential therapeutic agent against other diseases and conditions. Its potential applications are being investigated beyond cancer therapy, highlighting its versatility in pharmaceutical research and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 20167-22-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,1,6 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 20167-22:
(7*2)+(6*0)+(5*1)+(4*6)+(3*7)+(2*2)+(1*2)=70
70 % 10 = 0
So 20167-22-0 is a valid CAS Registry Number.
20167-22-0Relevant articles and documents
NOVEL COMPOUND, ORGANIC CATION TRANSPORTER 3 DETECTION AGENT, AND ORGANIC CATION TRANSPORTER 3 ACTIVITY INHIBITOR
-
Paragraph 0753-0754; 0756, (2016/08/17)
[Problem] The present invention addresses the problem of providing a novel compound. The present invention also addresses the problem of providing an OCT3 detection agent or an OCT3 activity inhibitor, which comprises the novel compound. [Solution] A compound represented by formula (A), a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof. ????????R1-R2-R3-R4?????(A)
